Solution rose Tantum vaginas. 1mg / ml 140ml vial 5 pcs

Description

Composition
Active substance:
100 ml solution contains: 0.1 g of benzydamine hydrochloride ;.
Excipients:
Benzalkonium chloride; disodium edetate; ethanol 96%; polysorbate 20; rose oil; purified water.
Description:
Colorless transparent liquid with a characteristic odor of roses.
Product form:
Vaginal solution 0.1%:
140 ml of the drug in vial polyethylene pink color, with the cannula having a cover with a white-return valve and the guide nozzle, with a translucent lid for protecting and sealing the cannula.
Five bottles, together with instructions for use placed in a cardboard box.
Contraindications
Hypersensitivity to any component of the drug.
Dosage
1 mg / ml
Indications
In the postpartum period as a therapeutic and prophylactic agent for the prevention of postpartum infectious complications; specific vulvovaginitis (in combination therapy); nonspecific vulvovaginitis and cervicovaginitis of any etiology, including a second evolved during chemotherapy and radiotherapy; bacterial vaginosis; prevention of postoperative infectious complications in operative gynecology.
Interaction with other drugs
Not identified clinically significant drug interactions Tantum® Rose with other drugs.
Overdose
Currently, the cases of drug overdose rose Tantum® were reported.
pharmachologic effect
Pharmacological group:
Nonsteroidal anti-inflammatory drug.
Pharmacodynamics:
Benzydamine is a non-steroidal anti-inflammatory drug that belongs to a group of indazoles.
Anti-inflammatory and local anesthetic effect, antibacterial, antifungal and antiseptic action.
The mechanism of action of the drug associated with the stabilization of cell membranes and inhibition of prostaglandin synthesis.
Benzydamine has a specific antibacterial and antimicrobial action due to the rapid penetration through the membrane of microorganisms with consequent damage to cell structures, disturbance of metabolic processes and cell lysosomes.
It has an antifungal activity against Candida albicans. It causes structural modification of the cell wall of fungi and their metabolic chains thus prevents their reproduction, which was the basis for the use of benzydamine in inflammatory processes, including infectious etiology.
Pharmacokinetics:
When applied topically, the drug is well absorbed through mucous membranes and penetrate into the inflamed tissue. Excretion of the drug takes place mainly through the kidneys and intestines as metabolites or conjugation product.
Pregnancy and breast-feeding
There are no contraindications to the topical application of the drug Tantum® rose during pregnancy and lactation (breastfeeding) are absent.
Conditions of supply of pharmacies
Without recipe.
side effects
In rare cases, possible allergic reactions, dryness of the oral mucosa.
special instructions
Long-term use of the drug can lead to increased sensitivity.
Using the drug for long periods, it is necessary to consult a doctor.
Effects on ability to drive vehicles and management mechanisms: the use of the drug does not affect the ability to drive vehicles, to engage in other potentially hazardous activities that require high concentration and psychomotor speed reactions.
Storage conditions
At temperatures above 25 ° C, protected from light.
Keep out of the reach of children!.
Dosing and Administration
Vaginally.
Vaginal solution 0.1%: the solution in the vial, which is a disposable syringe, ready for use.
The contents of the vial must be heated in a water bath to body temperature. The procedure should be done lying down, the liquid should remain in the vagina for several minutes. For single use the entire irrigation bottle of 140 ml volume.
In the postnatal period as a therapeutic and prophylactic agent for accelerating the process of rehabilitation and prevention of postpartum infectious complications: vaginal irrigation 1 time per day for 3-5 days.
In bacterial vaginosis: vaginal irrigation 1 – 2 times a day for 7 – 10 days; with nonspecific vulvovaginitis and cervicovaginitis of any etiology, including a second evolved during chemotherapy and radiotherapy: 2 times a day for at least 10 days.
When specific vulvovaginitis, as a part of complex therapy: 2 times a day, 3-5 days; prevention of postoperative complications in operative gynecology: 1 times per day for 3-5 days.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist